Vertex Pharmaceuticals Incorporated VRTX
526.19
3.81
0.73%
as of 25 Sep
- Market cap
- $132.3B
- P/E
- 30.4×
Follow VRTX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 23.54% | 24.20% | 22.54% | 22.31% |
+8 more TTM periods Free account |
|
| 17.12% | 17.58% | 16.41% | 15.60% | ||
ROIC |
24.09% | 24.15% | 21.63% | 22.62% | |
Return on Tangible Assets |
42.89% | 45.87% | 44.62% | 48.87% | |
Average Days of Receivables |
61.89 | 59.63 | 62.43 | 60.60 | |
Free Cash Flow per Share |
14.96 | 14.60 | 12.49 | 13.06 | |
Free Cash Flow |
3,796.10 | 3,710.30 | 3,193.80 | 3,337.20 | |
Capital Expenditures |
(496.80) | (530.30) | (437.60) | (380.80) | |
Piotroski F-Score |
4.00 | 7.00 | 7.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
15.28% | 15.94% | 14.37% | 15.75% | |
Accounts Receivable Turnover |
6.25 | 6.43 | 6.55 | 6.34 | |
Accounts Payable Turnover |
4.04 | 3.60 | 3.78 | 3.94 | |
Inventory Turnover |
1.08 | 1.08 | 1.14 | 1.19 | |
Average Days of Payables |
88.93 | 106.24 | 102.05 | 95.36 | |
Days of Inventory on Hand |
365.48 | 383.59 | 372.85 | 369.11 | |
Tax Rate |
(0.16) | (0.16) | (0.15) | (0.17) | |
Research and Development Expense of Revenue |
31.04% | 31.85% | 32.58% | 33.56% | |
Selling, General and Administrative Expense of Revenue |
15.95% | 15.14% | 14.61% | 14.02% | |
Share Based Compensation of Revenue |
5.47% | 5.62% | 5.72% | 5.94% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.97 | 0.98 | 0.92 | 1.01 | |
Depreciation/Fixed assets |
0.13 | 0.14 | 0.14 | 0.14 | |
Capex/Depreciation |
(2.24) | (2.44) | (2.09) | (1.90) | |
Revenue per Share |
49.61 | 48.08 | 46.94 | 45.87 | |
Operating CF per Share |
16.92 | 16.69 | 14.20 | 14.55 | |
Capex per Share |
(1.96) | (2.09) | (1.71) | (1.49) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.03 | |
Net Profit Margin |
35.00% | 35.51% | 32.94% | 31.35% |
Columns are period end dates